{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:31:43Z","timestamp":1790775103786,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.amjmed.2016.12.029","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T01:16:44Z","timestamp":1484788604000},"page":"746.e1-746.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome"],"prefix":"10.1016","volume":"130","author":[{"given":"Allison J.","family":"Kasmari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2025-365X","authenticated-orcid":false,"given":"Amy","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McGarrity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2016.12.029_bib1","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.amjmed.2016.12.029_bib2","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice","volume":"13","author":"Singal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2016.12.029_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.510310211","article-title":"Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience","volume":"31","author":"Yuen","year":"2000","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.amjmed.2016.12.029_bib4","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2004.07.020","article-title":"Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study","volume":"127","author":"Davila","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2016.12.029_bib6","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1007\/s10620-015-3821-7","article-title":"Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience","volume":"60","author":"Perumpail","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.amjmed.2016.12.029_bib7","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ijc.26165","article-title":"Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies","volume":"130","author":"Wang","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.amjmed.2016.12.029_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ajg.2011.384","article-title":"Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study","volume":"107","author":"Lai","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2016.12.029_bib9","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1111\/j.1572-0241.2001.04054.x","article-title":"The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans","volume":"96","author":"El-Serag","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"suppl","key":"10.1016\/j.amjmed.2016.12.029_bib10","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of hepatocellular carcinoma: consider the population","volume":"47","author":"Mittal","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.amjmed.2016.12.029_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/aje\/155.4.323","article-title":"Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women","volume":"155","author":"Donato","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.amjmed.2016.12.029_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients","volume":"112","author":"Fatttovich","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2016.12.029_bib13","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/ajg.2013.160","article-title":"Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"108","author":"Welzel","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2016.12.029_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2016.12.029_bib15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cgh.2007.02.039","article-title":"Incidence and predictors of hepatocellular in patients with cirrhosis","volume":"5","author":"Ioannou","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2016.12.029_bib16","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/hep.27014","article-title":"Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly","volume":"59","author":"Chieng","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2016.12.029_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","article-title":"Metabolic syndrome increases the risk of primary liver cancer in the United States: a population-based case-control study","volume":"54","author":"Welzel","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2016.12.029_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.26338","article-title":"Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults","volume":"131","author":"Borena","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.amjmed.2016.12.029_bib19","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2016.12.029_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4251\/wjgo.v5.i9.186","article-title":"Primary hepatocellular carcinoma and metabolic syndrome: an update","volume":"5","author":"Rahman","year":"2013","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"10.1016\/j.amjmed.2016.12.029_bib21","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.amjmed.2016.12.029_bib22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jama.286.10.1195","article-title":"The continuing epidemics of obesity and diabetes in the United States","volume":"286","author":"Mokdad","year":"2001","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.amjmed.2016.12.029_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4254\/wjh.v7.i8.1105","article-title":"Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: role of statins and metformin","volume":"7","author":"Ampuero","year":"2015","journal-title":"World J Hepatol"},{"issue":"7","key":"10.1016\/j.amjmed.2016.12.029_bib24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/apt.13341","article-title":"Increased risk of hepatocellular carcinoma in chronic hepatitis C with new-onset diabetes: a nation-wide cohort study","volume":"42","author":"Huang","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2016.12.029_bib25","first-page":"333","article-title":"Epidemiology of the metabolic syndrome in the USA","volume":"12","author":"McCullough","year":"2011","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.amjmed.2016.12.029_bib26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/ajg.2010.475","article-title":"Statin use and the risk of liver cancer: a population-based case-control study","volume":"106","author":"Chiu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2016.12.029_bib27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2011.36.0917","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection","volume":"30","author":"Tsan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjmed.2016.12.029_bib28","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2012.44.6831","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection","volume":"31","author":"Tsan","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.amjmed.2016.12.029_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0035-1564093","article-title":"The safety and benefit of statins in liver cirrhosis: a review","volume":"123","author":"Souk","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"8","key":"10.1016\/j.amjmed.2016.12.029_bib30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ajg.2015.203","article-title":"Prevalence of cirrhosis in hepatitis c patients in the chronic hepatitis cohort study: a retrospective and prospective observational study","volume":"110","author":"Gordon","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.amjmed.2016.12.029_bib31","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1021\/acs.molpharmaceut.5b00577","article-title":"Metformin: a novel but controversial drug in cancer prevention and treatment","volume":"12","author":"Sui","year":"2015","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.amjmed.2016.12.029_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11864-015-0359-z","article-title":"The role of aspirin, vitamin D, exercise, diet, statins, and metformin in the prevention and treatment of colorectal cancer","volume":"16","author":"Sehdev","year":"2015","journal-title":"Curr Treat Options Oncol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934317300347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934317300347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:12:07Z","timestamp":1757581927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934317300347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0002934317300347"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2016.12.029","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2016.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}